AGEN-2041

N/A

Report date: 2024/07/31 09:53:48

Base Information

Drug NameAGEN-2041

Drug Alias NameAGEN-2041

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human

Mechanisms of ActionAnti-CTLA4

TargetsCytotoxic T-Lymphocyte-Associated Antigen 4

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesAgenus Inc

China Registration ClassN/A

Active CompaniesAgenus Inc

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

ATC CodeN/A